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PA from an H5N1 highly pathogenic avian
influenza virus activates viral transcription and
replication and induces apoptosis and interferon
expression at an early stage of infection
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Abstract
Background: Although gene exchange is not likely to occur freely, reassortment between the H5N1 highly
pathogenic avian influenza virus (HPAIV) and currently circulating human viruses is a serious concern. The PA
polymerase subunit of H5N1 HPAIV was recently reported to activate the influenza replicon activity.
Methods: The replicon activities of PR8 and WSN strains (H1N1) of influenza containing PA from HPAIV
A/Cambodia/P0322095/2005 (H5N1) and the activity of the chimeric RNA polymerase were analyzed. A reassortant
WSN virus containing the H5N1 Cambodia PA (C-PA) was then reconstituted and its growth in cells and
pathogenicity in mice examined. The interferon promoter, TUNEL, and caspase 3, 8, and 9 activities of C-PA-infected
cells were compared with those of WSN-infected cells.
Results: The activity of the chimeric RNA polymerase was slightly higher than that of WSN, and C-PA replicated
better than WSN in cells. However, the multi-step growth of C-PA and its pathogenicity in mice were lower than
those of WSN. The interferon promoter, TUNEL, and caspase 3, 8, and 9 activities were strongly induced in early
infection in C-PA-infected cells but not in WSN-infected cells.
Conclusions: Apoptosis and interferon were strongly induced early in C-PA infection, which protected the
uninfected cells from expansion of viral infection. In this case, these classical host-virus interactions contributed to
the attenuation of this strongly replicating virus.
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Background
Influenza A viruses cause disease in humans, pigs, other
mammals, and birds [1]. The genomes of influenza A
viruses are composed of 8 negative-sense single-stranded
RNA segments; this segmented genome allows gene
reassortment between viruses in co-infected cells to pro-
duce new viruses. Reassortment of influenza A virus
genes caused the deadly H2N2 “Asian flu” and the
H3N2 “Hong Kong flu” pandemics in 1957 and 1968, re-
spectively. During these pandemics, the avian virus PB1,
HA and NA, or PB1 and HA genes, respectively, were
introduced into circulating human viruses [2,3]. The last
pandemic strain, the novel swine-origin influenza virus
A/H1N1 (S-OIV), carries PB2 and PA genes of avian ori-
gin [4]. In addition to the S-OIV pandemic flu, H5N1
highly pathogenic avian influenza viruses (HPAIV) have
caused severe or fatal disease in humans in Asia, the
Middle East, and Africa since their emergence in Hong
Kong in 1997 (WHO, http://www.who.int/csr/disease/
avian_influenza/en/). The H5N1 influenza virus ribonu-
cleoprotein complex (RNP) contributes to viral patho-
genesis in chickens [5,6]. Influenza viruses with high
polymerase activity have also shown high pathogenicity
[7,8]. These lines of evidence suggest that the influenza
RNA-dependent RNA polymerase (RdRp) contributes to
its pathogenesis.
Influenza A virions contain 8 negative-sense single-
stranded RNA genome segments and RdRp [9]. Genome
segments 1, 2, and 3 encode the RdRp subunits PB2, PB1,
and PA, respectively. Segment 4 encodes hemagglutinin
(HA), segment 5 nucleoprotein (NP), segment 6 neur-
aminidase (NA), segment 7 matrix protein 1 (M1) and an
ion channel (M2), and segment 8 non-structural protein 1
(NS1) and nuclear export protein (NEP). A second open
reading frame of segment 2 encodes PB1-F2 in some
strains.
The RdRp subunit PB1 is the core subunit of the RdRp
complex and mediates RNA polymerization [10-12], while
PB2 is the cap-binding subunit [13-15] and PA has cap-
dependent endonuclease activity [16-20]. Influenza virus
RdRp catalyzes both transcription of viral mRNA and rep-
lication of the viral genome. Influenza transcription is a
prototype of primer-dependent initiation. The viral RdRp
binds to the cap-1 structures of host mRNAs and cleaves
off 9 to 15 nucleotides to generate primers for viral tran-
scription, a process known as “cap snatching” [13,21-23].
The internal initiation mechanism of influenza virus gen-
ome replication was recently elucidated [24,25].
H5N1 HPAIV does not efficiently adapt to transmis-
sion to humans [26]. However, once it does infect
humans, it results in high mortality of approximately
60% [27,28]. Although some genomic combinations,
such as those between human H3N2, avian H5N1, and
horse H7N7 or between human H3N2 and avian H2N2,
may be incompatible [29-32], reassortment between
H5N1 HPAIV, which is epizootic among poultry almost
worldwide [33], and currently circulating human influ-
enza viruses, including the pandemic S-OIV and sea-
sonal influenza viruses (H1N1 and H3N2), is one of the
most important potential threats for the next pandemic.
Kashiwagi et al. recently reported that the PA of H5N1
HPAIV activated the polymerase activity by enhancing
promoter binding [34]. Multiple functions of PA in
addition to promoter binding, such as transcription and
replication [9,18], endonuclease activity [16,17,19,20,35],
cap binding [19], protease activity [36], proteolysis in-
duction [37], pathogenesis in mice [38], and thermal
sensitivity of RNP [39], have been identified.
In this paper, we describe the activation of the poly-
merase activity of A/Puerto Rico/8/1934 (PR8, H1N1)
and A/WSN/1933 (WSN, H1N1) RNPs by the H5N1
HPAIV PA of A/Cambodia/P0322095/2005, which was
isolated from a Cambodian victim [40], and the reconsti-
tution of the chimeric virus to analyze the effect of this
H5N1 PA in the background of WSN, a well-studied
mouse influenza infection model. We found a discrep-
ancy between the viral polymerase activity and prolifera-
tion efficiency in cells and its pathogenesis in mice. We
then analyzed the mechanism of the attenuation and the
low pathogenicity of WSN carrying H5N1 PA.
Results
Effect of H5N1 Cambodia PA on the PR8 and WSN
replicons and in vitro RdRp activity
We first examined the replicon activity in 293 T cells
of a chimeric PR8 RNP containing H5N1 Cambodia PA
(Figure 1A). Influenza replicon activity was measured as
previously described [41,42]. The replicon activity was
about 200.0 ± 8.2% that of the PR8 RNP (Student’s t;
p< 0.005), while the Cambodia RNP showed 43.8 ± 2.9%
of the replicon activity of the PR8 RNP (p< 0.005). The
expression of RdRp and NP in the transfected cells was
confirmed by western blotting (Additional file: Figure S1).
As we found 2-fold activation of the PR8 replicon by
H5N1 Cambodia PA, we purified both PR8 RdRp and a
chimeric RdRp (PR8PB2-PR8PB1-H5N1 Cambodia PA)
in order to investigate the effect of the H5N1 Cambodia
PA on RdRp activity in vitro. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) showed
that H5N1 Cambodia PA migrated to a higher position
than did PR8PA; the Cambodia PA band almost over-
lapped with that of 18 ×HisPR8PB2 (Figure 1B). The
identity of H5N1 Cambodia PA was confirmed by west-
ern blotting against PA (Figure 1C).
We next compared the activities of the purified RdRps
in vitro. We tested the transcription activity using v84
and globin mRNA primers (Figure 1D and E, mRNA),
and replication activity using v84 and c84 with and
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without the dinucleotide primer ApG (Figure 1D, E, F,
and G). ApG-primed and de novo initiation of v84 tran-
scription produced 84- and 83-nt products, respectively,
while globin mRNA-primed transcription produced 96-
nt products. Because virion RdRp uses 10–15 nucleotide
primers to initiate from the C at the 2nd position from
the 3′ end of the genome [18,22], the 96-mer products
were assigned to the transcripts from the 13th G next to
the 12th U of the cap-1 structure (m7GmACACUUG-
CUUUU) of rabbit β-globin mRNA (GenBank; M10843).
The mean and standard deviation (error bar in the
graph) of the polymerase activity relative to that of PR8
RdRp were calculated from 2 independent measure-






































































































































Figure 1 Replicon and in vitro RNA-dependent RNA polymerase (RdRp) activities of the chimeras of H5N1 Cambodia PA with PR8 and
WSN. A: Replicon activity of the chimeric influenza virus ribonucleoproteins (RNPs) of WSN and PR8 with H5N1 Cambodia PA. The relative
replicon activities of WSN and PR8 with H5N1 Cambodia PA in 293 T cells were compared with those of WSN and PR8. The combination of PB2,
PB1, PA, and NP is indicated below the graph. W, WSN; P, PR8; C, H5N1 Cambodia. As a negative control, PR8 replicon without PA was used. B:
Purified influenza virus PR8 RdRp (P) and PR8PB2-PR8PB1-C-PA RdRp (C). Each RdRp (5 pmol) was subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) on 7.5% gels and Coomassie brilliant blue staining. The positions of PB1, 18 ×His-PB2, and PA are
indicated on the left. C: Western blot of the purified influenza virus chimeric RdRp. Each RdRp (5 pmol) was electro-blotted onto the
nitrocellulose membrane. The PA was detected by western blotting with anti-PA antibodies. The position of PA is indicated on the left. D and E:
Comparison of the chimeric RdRp activities in in vitro transcription and replication of v84 with those of PR8. The v84 model template RNA (200
nM) was transcribed by PR8RdRp (P) or PR8PB2-PR8PB1-C-PA RdRp (C) with or without (de novo) 0.1 mM ApG (ApG) or 0.5 μg globin mRNA
(mRNA). F and G: Comparison of chimeric RdRp activity in in vitro replication of c84 with that of PR8. The c84 model template RNA was
incubated with or without ApG (de novo). Products were analyzed by PAGE on 6% gels containing 8 M urea and the images analyzed with a
Typhoon Trio plus. Examples of the images are shown in D and F. The size of the product RNA is indicated on the left. The mean and standard
deviation (error bar in the graph) of the polymerase activity relative to that of PR8 RdRp were calculated from 2 independent measurements of 3
different RdRp preparations. Statistical significance was evaluated with Student’s t-test. *p< 0.05, ***p< 0.005.
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ApG-primed replication activity of the chimeric RdRp
was 95.9 ± 4.5% of that of PR8 RdRp, while its de novo
replication activity was 126 ± 40% of that of PR8 RdRp.
The chimeric RdRp produced 171 ± 31% (p< 0.05) of
the amount of 96-nt transcription products. ApG-
primed initiation of c84 produced 84- and 81-nt pro-
ducts, while de novo initiation produced 81-nt products.
The relative replication activity of ApG-primed initiation
of c84 by the chimeric RdRp was 116 ± 16% of that by
PR8 RdRp, while its de novo initiation was 156 ± 29% of
that by PR8 RdRp (p< 0.05). We thus confirmed that
H5N1 Cambodia PA enhanced both the transcription
and replication activities of PR8 RdRp.
Before reconstituting WSN carrying H5N1 Cambodia
PA, we tested the effect of H5N1 Cambodia PA on the
WSN replicon (Figure 1A). WSN replicon activity
(91.3 ± 3.2%) was similar to that of PR8. The replicon ac-
tivity of WSN containing the H5N1 Cambodia PA
(which was 133.9 ± 5.8% of that of the PR8 replicon)
was about 1.5-fold higher than that of the WSN replicon
(p< 0.005). Therefore, we also observed an activation ef-
fect of H5N1 Cambodia PA on the WSN replicon.
Effect of H5N1 Cambodia PA on virus growth in MDCK
cells, chicken embryo fibroblasts (CEF), and Vero cells
Next, we tested whether the RdRp activation effect of
H5N1 Cambodia PA affected virus growth. As the RdRp
subunits of PR8 and WSN are highly homologous, with
96, 97, and 98% amino acid identity between the PB2,
PB1, and PA genes, respectively, and as the activation ef-
fect of H5N1 Cambodia PA was confirmed in both the
WSN and PR8 replicons, we used a WSN reconstitution
system to analyze the effect of H5N1 Cambodia PA in
H1N1 virus. The WSN virus carrying H5N1 Cambodia
PA (C-PA) was reconstituted successfully. First, we com-
pared the multi-step growth of C-PA with that of WSN
in MDCK, CEF, and Vero cells.
In MDCK cells, the C-PA titer was always lower than
that of WSN and plateaued (4.7 ± 0.2 × 104 PFU/mL)
16 hr post-infection (pi), while the WSN titer was
2.2 ± 0.03 × 105 PFU/mL 16 hr pi and plateaued
(5.6 ± 1.6 × 106 PFU/mL) 36 hr pi (Figure 2A). The C-PA
titer in MDCK cells 60 hr pi was significantly higher
than that of WSN (p< 0.001). The titers of C-PA and
WSN in CEF did not plateau even 60 hr pi. However,
the C-PA titer 60 hr pi (7.1 ± 1.4 × 105 PFU/mL) was
about half of that of WSN (1.3 ± 0.4 × 106 PFU/mL), a
statistically significant difference (p< 0.001, Figure 2B).
We therefore observed a discrepancy between the effects
of H5N1 Cambodia PA on RdRp activity and on virus
growth in MDCK and CEF cells. However, the C-PA
titer in Vero cells between 24 hr and 60 hr pi was sig-
nificantly higher than that of WSN (p< 0.05, Figure 2C).







































































Figure 2 Multi-step growth curves of C-PA and WSN in infected cells. MDCK (A), chicken embryo fibroblast (CEF) (B), and Vero (C) cells were
infected with C-PA or WSN at a multiplicity of infection (MOI) of 0.01. Viruses were harvested 8, 16, 24, 36, 48, and 60 hr (additional 72 and 90 hr
for Vero cells) after infection and their titers on MDCK cells measured by a plaque-formation assay. The mean and standard deviation (error bar in
the graph) of each plaque titer were calculated from 3 independent experiments. Statistical significance was evaluated with Student’s t-test.
**p< 0.01, ***p< 0.005.
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No cytopathic effect was apparent in Vero cells (data
not shown).
We next compared single-step growth of C-PA and
WSN in MDCK and Vero cells (Figure 3). The C-PA
titers in both MDCK and Vero cells between 4 and
12 hr pi were higher than those of WSN. The C-PA titer
in MDCK cells 12 hr pi (1.6±0.9×106 PFU/mL) was sig-
nificantly higher than that of WSN (1.3±0.7×105 PFU/mL)
(p< 0.005, Figure 3A). The C-PA titer in Vero cells 12 hr pi
(1.6 ± 0.9 × 105 PFU/mL) was significantly higher than
that of WSN (2.9±0.2×104 PFU/mL) (p< 0.05, Figure 3B).
The growth of C-PA in both MDCK and Vero cells plat-
eaued 6 hr pi. WSN growth in Vero cells plateaued 8 hr pi,
while its titer in MDCK cells continued to increase up to
12 hr pi.
Pathogenicity of the C-PA virus in mice
We also examined the pathogenicity of C-PA in mice.
The LD50 for mouse nasal infection was calculated from
the survival rate of the infected mice by the method of
Reed and Münch (Figure 4) [43]. The LD50 values of
C-PA and WSN were 5 × 105 PFU and 1 × 104 PFU, re-
spectively. The pathogenicity of C-PA is therefore lower
than that of WSN, despite its higher RdRp activity, both
in cell culture (as reflected by the multi-step growth)
and in mice.
We thus confirmed the discrepancy between the RdRp
activity and pathogenicity both in cells (virus titer) and
in mice. The genome sequence of the C-PA stock was
confirmed to be identical to that of the genome reconsti-
tution plasmids.
Interferon induction
Because the multi-step growth activity of C-PA was
lower than that of WSN in MDCK and CEF cells but
better in Vero cells, and because the single-step growth
activity of C-PA was better than that of WSN in both









































Time post infection (hr)
***
*
Figure 3 Single-step growth curves of C-PA and WSN in infected cells. MDCK (A) and Vero (B) cells were infected with C-PA or WSN at an
MOI of 5. Viruses were harvested 2, 4, 6, 8, 10, and 12 hr after infection and their titers on MDCK cells measured by a plaque-formation assay. The
mean and standard deviation (error bar in the graph) of each plaque titer were calculated from 3 independent experiments. Statistical
significance was evaluated with Student’s t-test. *p< 0.05, ***p< 0.005.
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on the activity of the host cellular defense system. First,
we examined interferon β induction in 293 T cells by
measuring the activity of its promoter (Figure 5). A
small amount of interferon β was induced in cells
infected with either C-PA or WSN 4 hr pi. However,
interferon β promoter activity was almost 3-fold higher
(p< 0.01) in the C-PA-infected cells than in the WSN-
infected cells 8 hr pi.
TUNEL assay
Next, we examined the induction of apoptosis in MDCK
cells by performing TUNEL assays hourly from 8 to
16 hr pi and once more 24 hr pi. The numbers of
TUNEL-positive cells in 3 random fields were counted
(Figure 6A). Before 11 hr pi, we found fewer than 5
TUNEL-positive cells per field in either C-PA- or WSN-
infected cells. Then, beginning 12 hr pi, the numbers of
the C-PA-infected TUNEL-positive cells increased to
20 ± 3.5 (12 hr), 27 ± 2.5 (13 hr), 41 ± 4.0 (14 hr), 46 ± 2.6
(15 hr), 48 ± 2.6 (16 hr), and 28 ± 3.5 (24 hr). The num-
bers of the WSN-infected TUNEL-positive cells
remained less than 6 until 16 hr and then increased to
40 ± 4.6 at 24 hr pi. From 12 to 16 hr pi, significantly
more TUNEL-positive cells were observed among the
C-PA-infected cells than among the WSN-infected cells
(p< 0.005). TUNEL-positive cells were clearly observed
among both C-PA- and WSN-infected cells, and signifi-
cantly more TUNEL-positive cells were observed among
WSN-infected cells than among C-PA-infected cells
24 hr pi (p< 0.05). In conclusion, TUNEL-positive cells
appeared earlier in C-PA-infected cells than in WSN-
infected cells. No differences in TUNEL staining were
found among cells transfected with WSN and H5N1
Cambodia single-protein-expression plasmids (PB2, PB1,
PA, HA, NP, NA, M1, M2, NS1, and NS2) or pcDNA3.1
(data not shown).
Caspase 3, 8, and 9 activities
TUNEL-positive cells may be apoptotic. Caspases are cen-
tral players in both the intrinsic and the extrinsic pathways
of apoptosis [44-46]. We therefore measured the activities
of caspases 3, 8, and 9 in C-PA- and WSN-infected cells
10 hr pi, 2 hr before TUNEL-positive cells could first be
observed among C-PA-infected cells, in order to confirm
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Figure 4 Survival curve of mice infected with C-PA or WSN. Groups of 4 mice were inoculated intra-nasally with 106, 105, 104, or 103 plaque-
forming units (PFU) of C-PA (A) or 105, 104, or 103 PFU of WSN (B) in a volume of 50 μL. The survival curves of the mock-infected (C) and non-




























Figure 5 Interferon β expression in C-PA- and WSN-infected
cells. Interferon induction levels 4 and 8 hr pi were measured as the
luciferase activity from p-125Luc. The mean and standard deviation
(error bar) of luciferase activity were calculated from 3 independent
measurements. Statistical significance was evaluated with Student’s
t-test. **p< 0.01.
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the induction of apoptosis (Figure 6B). The activities of
caspases 3 (14.7 ± 9.8 × 106 RFU/mg protein, p< 0.0005),
8 (3.6 ± 0.2 × 106 RFU/mg protein, p< 0.005), and 9
(1.5± 0.5 × 106 RFU/mg protein, p< 0.005) were higher in
C-PA-infected cells than in WSN-infected cells 10 hr pi
(comparisons evaluated by Student’s t test). The caspase
activities in WSN-infected cells were similar to those in
mock-infected cells, indicating that WSN infection did
not induce apoptosis 10 hr pi. The activation of caspase 9
in C-PA-infected cells indicates that C-PA infection
induces apoptosis through the mitochondrial pathway
[47-49], and the apoptosis induction by C-PA began at an
early time after infection at which no apoptosis was
induced by WSN infection.
Histopathology and TUNEL assay of infected mice
Finally, we compared the pathological changes in the
lung between C-PA- and WSN-infected mice. The
histopathological appearances were similar (Figure 7).
The major difference between C-PA- and WSN-infected
lungs is that pulmonary edema around blood vessels was
present in the C-PA-infected lungs from day 1 pi, al-
though it was also present in WSN-infected lungs on
days 3 and 4 pi. On the first day of infection, a moderate
amount of lymphocyte infiltration was observed around
the bronchioles of C-PA-infected mouse lungs, and this
inflammation decreased on days 3 and 4. More lympho-
cyte infiltration around the bronchioles was observed in
WSN-infected mouse lungs on days 1–3, with the most
severe inflammation on day 2, and only mild inflamma-
tion was observed on day 4. No pathological change was
observed in the mock-infected or non-infected mouse
lungs.
We simultaneously analyzed these samples by TUNEL
assay. A few TUNEL-positive cells were observed in both
C-PA- and WSN-infected mouse lungs on days 1–4 pi,
Figure 6 TUNEL staining and Caspase 3, 8, and 9 activities of C-PA- and WSN-infected cells. A. TUNEL assays were performed on C-PA-
and WSN-infected MDCK cells at the indicated time after infection. The mean and standard deviation (error bar) of the number of TUNEL-positive
cells counted from 3 random fields were calculated. B. The activities of caspases 3, 8, and 9 in C-PA- and WSN-infected MDCK cells were
measured 10 hr pi. Caspase activity is expressed as the fluorescence intensity/total cellular protein (mg) calculated from 3 independent
measurements. Mock: mock-infected MDCK cells. Statistical significance was evaluated with Student’s t-test. *p< 0.05, ***p< 0.005, ****p< 0.0005.
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but the numbers did not clearly differ between the 2
viruses. The histopathological findings indicated recov-
ery of the C-PA-infected mouse lungs, which is consist-
ent with the lower pathogenicity of C-PA.
Discussion
The activation of replicon activity by H5N1 HPAIV PA
observed in this study has been reported several times
(Figure 1) [34,50,51]. Influenza viruses with high poly-
merase activity have been reported to show high patho-
genicity [7,8]. Therefore, reassortment of H5N1 HPAIV
PA into human influenza viruses, including the seasonal
influenza viruses (H1N1 and H3N2) and the pandemic
influenza virus (H1N1), is a serious concern [34], al-
though this event may not occur easily [32]. The major
factor for host adaptation in H5N1 HPAIV RNP is PB2,
which shows a strong correlation with pathogenicity in
mammalian hosts, including humans [30,31,51-55].
The WSN reconstitution system [56] was used to
analyze the effect of H5N1 Cambodia PA in an animal
influenza virus (H1N1). Contrary to our expectation, the
multi-step growth of C-PA in MDCK and CEF cells was
less than that of WSN, and its pathogenicity was low be-
cause of this attenuation (Figures 2, 4). We confirmed
the absence of mutations in the C-PA genome. As we
previously found a similar discrepancy in influenza pro-
moter/origin function due to a difference in activation of
the host defense system [42], we examined whether the
discrepancy between RdRp activity and pathogenicity
was also due to differences in host defense. As the
multi-step growth of C-PA in Vero cells was better than
that of WSN, and because its single-step growth, which
is highly dependent on the polymerase activity, in both
MDCK and Vero cells was better than that of WSN
(Figure 3), we first examined the activity of the inter-
feron β promoter and found that it was strongly acti-
vated (Figure 5) in CPA-infected cells.
Type I interferon is induced in virus-infected cells by a
signal transduction pathway beginning with retinoic-
acid-inducible gene-I (RIG-I), which recognizes 5′-
triphosphate-containing influenza RNA [57-62]. In C-
PA-infected cells, a large amount of vRNA was
expressed from early stages of infection, which might
more strongly trigger interferon induction (Figures 5
and Additional file: Figure S3) and thereby induce an
antiviral state in uninfected cells that protected them
from influenza infection (Additional file: Figure S2A)
[63-65]. The better multi-step growth of C-PA relative
to WSN in Vero cells, which are defective in type-I
interferon production [66] (Figure 2C), and the better
single-step growth of C-PA than of WSN (Figure 3), are
consistent with the high in vitro polymerase activity and
strong interferon induction in C-PA infected cells.
Apoptosis (programmed cell death) is another mech-
anism by which cells restrict viral infection including in-
fluenza [67]. However, virus-induced apoptosis causes
tissue damage, which is one of the mechanisms of influ-

















Figure 7 Histopathology of C-PA- and WSN-infected mouse lungs. The lungs of mice infected with C-PA or WSN (105 PFU/mouse) at the
indicated days after infection were imaged after hematoxylin and eosin (HE) or TUNEL staining. Control: non-infected mouse lung. The bar above
the picture indicates 100 μm and the bars in the fluorescence microgram indicate 200 μm.
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release of influenza viruses [69,70]. WSN induced apop-
tosis in MDCK cells late in infection [71]. However, no
apoptosis was induced by expression of any single pro-
tein of either WSN or H5N1 Cambodia. Apoptosis was
strongly induced in C-PA-infected cells beginning early
in infection when no apoptosis was induced in WSN-
infected cells (Figure 6). The activation of caspase 9 indi-
cated that this apoptosis was mediated through the
mitochondrial pathway [72]. The increased expression of
vRNA (Additional file: Figure S3) in C-PA infected cells
due to the high replication activity promoted by H5N1
PA (Figure 1) induced both interferon and apoptosis,
resulting in attenuation of C-PA proliferation (Figure 2).
Neither caspase 3 nor 8 was induced by expression of
WSN PA or Cambodia PA alone (data not shown). The
strong induction of interferon discussed above also sti-
mulates the induction of apoptosis via RNA-dependent
protein kinase (PKR) [73]. Such rapid induction of apop-
tosis was also observed in duck cells infected with
HPAIV [68]. However, in case of C-PA, early induction
of apoptosis attenuated the proliferation of the virus and
thus decreased its pathogenicity.
PB1-F2 is the only influenza virus protein that induces
apoptosis in infected monocytes and potentiates apop-
tosis during infection [74-76]. The WSN PB1-F2 pro-
teins of WSN and C-PA are identical. Kinetic analysis of
viral RNAs (Additional file: Figure S3) indicates that
PB1-F2 is unlikely to contribute to the strong induction
of apoptosis in C-PA infected cells.
C-PA infection strongly induced both interferon pro-
duction and apoptosis early in infection, which attenu-
ated virus proliferation and pathogenicity despite high
RdRp activity. This may be another reason, in addition
to poor adaptation, for the difficulty of obtaining reas-
sortant viruses carrying H5N1 HPAIV PA [31,32].
Methods
Cell culture
293 T and Vero cells were maintained in Dulbecco’s
modified Eagle minimal essential medium (DMEM) con-
taining 10% fetal bovine serum (FBS). CEFs were pre-
pared from 11-day-old embryonated chicken eggs by
trypsin digestion and stored in liquid nitrogen. CEF and
MDCK cells were maintained in DMEM containing 10%
or 5% FBS, respectively.
Replicon assay
A standard replicon assay was performed as previously
described [41,42,77]. Luciferase activity was measured
using the Dual-Glo luciferase assay kit and a GloMax 96
Microplate Luminometer (Promega, Fitchburg, USA)
after transfection of 0.1 μg each of pCPB2, pCPB1,
pCPA, pCNP, and ppolINSluc and 0.01 μg of pRLSV40
(Promega) using Lipofectamine 2000 (Invitrogen,
Carlsbad, USA). The PB2, PB1, PA, and NP genes of in-
fluenza A/Cambodia/P096/2005 (H5N1) [40] and A/WSN/
33 (H1N1) [56] were PCR-amplified using specific oligonu-
cleotides and cloned into pcDNA3.1(+) (Invitrogen), result-
ing in pcCamPB2wt, pcCamPB1, pcCamPA, pcCamNP,
pcWSNPB2, pcWSNPB1, pcWSNPA, and pcWSNNP, re-
spectively. Only data in which the variation of the
Renilla luciferase activity was less than 3-fold variations
were used. The oligonucleotide sequence information
will be made available upon request.
Expression, purification, and in vitro transcription of the
influenza virus RdRp
Expression, purification, and in vitro transcription of the
influenza virus RdRp were performed as previously
described [42,77,78]. Briefly, 100 nM influenza RdRp
was incubated in 50 mM Tris–HCl (pH 8.0), 8 mM
MgCl2, 150 mM NaCl, 2 mM DTT, 0.5 mM ATP,
0.5 mM CTP, 0.5 mM GTP, 0.05 mM [α-32P] UTP,
0.1 mM ApG or 0.01 mg/mL globin mRNA, 2000 U/mL
RNase inhibitor, and 200 nM v84 and c84 model tem-
plate RNA at 25 °C for 90 min. The product was ana-
lyzed by PAGE on 6% gels containing 8 M urea and the
images analyzed with a Typhoon Trio plus (GE Health-
care, Bucks, UK).
Model RNA templates
v84 and c84 model RNA templates were prepared as
previously reported [11].
Western blotting
Proteins were blotted onto nitrocellulose membranes
(Millipore, Billerica, USA) by semi-dry electroblotting
(Bio-Rad, Hercules, USA) after SDS-PAGE on 10% gels.
The blotted membranes were blocked with 10% skim
milk in 20 mM Tris–HCl (pH 7.5), 150 mM NaCl, and
0.02% Tween 20 (TBST), and western blotting was per-
formed using rabbit anti-PB1, -PB2, -PA [11], and -PR8
(1:1,000 each) and anti-actin (1:100) antibodies as the
primary antibodies. The membranes were then incu-
bated with alkaline phosphatase-conjugated anti-rabbit
IgG (1:7,500) or anti-mouse IgG (1:7,500), and the posi-
tions of the bound antibodies were visualized with nitro-
blue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl
phosphate (BCIP).
Reconstitution of influenza virus and plaque-formation
assay
pHH21 and the influenza virus 12-plasmid reconstitu-
tion system of WSN were kindly provided by Dr. Hobom
and Dr. Kawaoka [56]. The H5N1 A/Cambodia/
P0322095/2005 [40] PA sequence was inserted into
ppolI-WSN-PA, resulting in ppolI-Cam-PA. The influ-
enza virus WSN strain (WSN) and WSN carrying H5N1
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Cambodia PA (C-PA) were reconstituted by co-transfection
of 293 T cells with ppolI-WSN-PB2, ppolI-WSN-PB1,
ppolI-WSN-PA or ppolI-Cam-PA, ppolI-WSN-HA, ppolI-
WSN-NP, ppolI-WSN-NA, ppolI-WSN-M, and ppolI-
WSN-NS with pCPB2, pCPB1, pCPA, and pCNP [10,56]
using Lipofectamine 2000. The reconstituted viruses
were recovered from the culture media 72 hr post-
transfection. The viruses were plaque-purified, ampli-
fied, and titered on MDCK cells by a plaque-formation
assay and stored at −80 °C. The genome sequences of
all viruses were determined by RT-PCR. The primer
sequences used will be made available upon request.
Virus growth assay
MDCK, CEF, and Vero cells in 3.5-cm dishes (21 dishes
of MDCK cells and CEFs, 27 dishes of Vero cells per a
virus) were infected with WSN and C-PA at an MOI of
0.01 at 37 °C for 1 hr (multi-step growth assay). The
cells were washed 3× with phosphate-buffered saline
(PBS) and incubated with 2 mL of DMEM containing
2% FBS (without trypsin) at 37 °C, as WSN replicates
without trypsin [79]. All of the supernatants of 3 dishes
of each cell were taken 6, 12, 24, 36, 48, and 60 hr (and
also at 72 and 90 hr for Vero cells) after infection and
stored at −80 °C. Virus growth was also tested in MDCK
and Vero cells after infection at an MOI of 5 (single-step
growth assay). Supernatants were harvested 2, 4, 6, 8, 10,
and 12 hr after infection. The viruses in the supernatants
were titered on MDCK cells by a plaque-formation
assay.
Mouse infection
Groups of 4 6-week-old female BALB/c mice (Sino-Brit-
ish Laboratory Animal, Shanghai, China) were anesthe-
tized with ether and inoculated with 105, 104, or 103
PFU of WSN or 106, 105, 104, or 103 PFU of C-PA in a
volume of 50 μL by nasal dropping. Four mice were
inoculated with 50 μL of PBS as a mock-infection con-
trol. The survival rates were monitored daily and the
50% lethal doses (LD50s) calculated [41].
Histopathological analysis
Six-week-old female BALB/c mice were anesthetized
with ether and inoculated with 105 PFU of WSN or C-PA
in 50 μL by nasal dropping. Mice were inoculated with
50 μL of PBS as a mock-infection control. A non-treated
mouse was used as a non-treated control. The mock-
infected and infected mice were sacrificed by cervical
dislocation under anesthesia on days 1, 2, 3, and 4 after
infection, and their lungs were removed and fixed with
3.5% formalin/PBS at 25 °C for 2 days. The lungs were
embedded in paraffin blocks, sectioned at 4-μm thick-
ness, and stained with hematoxylin and eosin (HE).
TUNEL assay
Cells were placed on cover slips in 24-well plates and
infected with WSN or C-PA at an MOI of 0.01. Eight, 9,
10, 11, 12, 13, 14, 15, 16, and 24 hr after infection, cells
were fixed with 1% formalin/PBS. The TUNEL assay was
performed using the DeadEndTM Fluorometric TUNEL
system according to the company’s instructions. The
samples were observed using a fluorescence microscope
(Leica DM IRB, Leica, Wetzlar, Germany), and the num-
bers of TUNEL positive cells in 3 random fields were
counted.
Caspase activity
MDCK cells were plated in 10-cm-diameter plates and
infected with WSN or C-PA at an MOI of 0.01. 10 hr
after infection, the cells were harvested and the activities
of caspases 3, 8, and 9 measured using the Caspase-3/
CPP32 Fluorometric Assay kit, the Caspase 8/FLICE
Fluorometric Assay kit, and the Caspase 9 Fluorometric
Assay kit (Biovision, Inc., Milpitas, USA) according to
the manufacturer’s instructions.
Interferon induction
Interferon induction was analyzed by measuring the luci-
ferase activity of cells transfected with p-125Luc, which
was kindly provided by Dr. Fujita [80]. 293 T cells were
transfected with p-125Luc (1 μg) and pRLSV40 (100 ng).
Four hours post-transfection, the cells were infected with
WSN or C-PA at an MOI of 0.01. The interferon pro-
moter activity was measured as the luciferase activity
using the Dual-Glo luciferase assay kit and a GloMax 96
Microplate Luminometer (Promega) and normalized as
the firefly luciferase/Renilla luciferase activity ratio.
Chemicals and radioisotopes
Non-radiolabeled nucleotides were purchased from GE
Healthcare, [α-32P]UTP from New England Nuclear (Per-
kinElmer Life Sciences, Waltham, USA), and T7 RNA
polymerase, T4 nucleotide kinase, oligonucleotides,
human placental RNase inhibitor, and restriction enzymes
from Takara (Dalian, China). The RPAIII Ribonuclease
Protection Assay Kit was purchased from Ambion (Aus-
tin, USA). Anti-actin antibodies were purchased from
Sigma Aldrich (St. Louis, USA). The Dual-Glo luciferase
assay kit, DeadEndTM Fluorometric TUNEL system, alka-
line phosphatase-conjugated anti-rabbit and anti-mouse
IgG’s, NBT, and BCIP were purchased from Promega.
DMEM, FBS, Lipofectamine 2000, and Trizol reagent
were purchased from Invitrogen.
Statistical analysis
The statistical significance levels of the data were evalu-
ated by Student’s t-test, with p< 0.05 indicating statis-
tical significance.
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